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e22 Surgical Trainee Poster AbstractsType-3 endoleaks. Renal complications were seen in 3/11
patients, 2 acute kidney injuries resolved spontaneously. 1
patient re-admitted Day-19 with acute renal failure and
bilateral renal artery occlusion, underwent endovascular
recanalization and stenting of the left renal artery, remains
dialysis dependent. 2/11 have died at 21 and 60 months,
both from non-aneurysm related disease. One iliac limb has
been extended for 1b endoleak and sac expansion. 2/11
endoleaks are under surveillance.
Conclusions: Complex Endovascular Aneurysm Repair is
feasible in patients considered unsuitable for standard
endovascular. Mid-term results suggest this procedure is
durable, but long-term follow-up is essential and awaited.
Supervised Exercise Therapy (SET) in the Management of
Peripheral Arterial Disease: Factors Determining
Compliance and Functional Outcome
T. Aherne, S. Carr, E.A.H. Kheirelseid, D. Moneley, A. Leahy,
P. Naughton
Department of Vascular Surgery, Beaumont Hospital, Dublin 9, Ireland
Introduction: Peripheral arterial disease (PAD) is a common
condition associated with considerable morbidity. Super-
vised exercise therapy (SET) has emerged as an effective
option in the management of this patient cohort. Unfor-
tunately, poor compliance remains prevalent.
Aim: The aim of this study was to assess factors inﬂuencing
symptomatic improvement and SET participation.
Methods: This single-centre retrospective cohort study was
inclusive of all patients with conﬁrmed PAD referred for SET
between October 2010 and December 2013. Patient de-
mographics and compliance data were extracted from
medical records with phone interviews establishing sub-
jective outcomes.
Results: A total of ninety-eight patients were referred for
SET during the study period. The mean age was 69.2
(10.1) with 18% being female. Median follow-up was 25.1
months (IQ range 17.0e31.6). Overall, the mean number of
sessions attended was 19.5. Regarding symptomatic
improvement exercise compliance was associated with a
signiﬁcant improvement in symptoms (p ¼ 0.001). Other
factors including anatomical level of claudication
(P ¼ 0.042) and educational level (p ¼ 0.007) were found to
affect the outcome of SET. Multivariate analysis revealed
hypertension as a predictor of symptomatic outcome after
SET (p ¼ 0.045). Concerning compliance, ex-smokers
(p ¼ 0.021) and those previously diagnosed with hyper-
cholesterolemia (p ¼ 0.020) or ischemic heart disease
(p ¼ 0.029) had superior exercise compliance. Using linear
regression, smoking history (p ¼ 0.024) and quality of
symptoms (p ¼ 0.018) were identiﬁed as predictors of
compliance to SET.
Conclusion: Establishing exercise compliance remains chal-
lenging in the PAD cohort. Pre-exercise patient education
and optimization may result in improvements in function
and compliance.Explant of Aortic Stent Grafts Following Endovascular
Aneurysm Repair
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Introduction: Failure of endovascular aneurysm repair
(EVAR) may require explant of the stent graft in a subset of
patients.
Methods: Patients undergoing explant of EVAR were iden-
tiﬁed from a prospectively maintained online database, with
additional information obtained through retrospective
analysis of medical records.
Results: Over an 18 year period 1996e2014, there were 496
EVAR procedures performed in our institution for abdom-
inal aortic aneurysm. There were 11 explants, three of these
were referrals from other vascular centres. The average age
was 72 years (range 65e77). The median length of time
from implantation to explant was 33 months (range 0.3e
106). Overall 5/11 cases were elective procedures. In-
dications for elective explant were Type 1 endoleak (n ¼ 1),
type 2 endoleak with increasing sac size (n ¼ 1), type 4
endoleak (n ¼ 1), increasing sac size without evident
endoleak (n ¼ 1) and stent migration not amenable to
endovascular revision (n ¼ 1).
The remaining 6 cases were emergency procedures, with
three patients presenting with rupture post EVAR, and two
patients presenting with acute stent thrombosis. The
remaining patient presented emergently with aorto-enteric
ﬁstula with a known infected EVAR stent. There were no
mortalities in the elective group and two mortalities (33%)
in the emergency group.
Conclusion: Endoleak remains the most common indication
for EVAR explant. Explant of aortic stent grafts in an elective
setting is a safe and effective treatment option.
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Even a Small Change can Still Make a Difference
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A.L. Leahy, D. McNamara
Department of Surgery, Beaumont Hospital, Dublin, Ireland
Background: Session starting time is one of the key factors
of TPOT and represent a recognized measure of theatre
efﬁciency as late start is associated with list overrunning
and patient cancelation. We aimed to investigate the
vascular list start time in our institution and to implement
interventions in order to minimize delay.
Methods: Data was collected from a prospectively updated
theatre database and medical notes. SPSS 22 was used for
statistical analysis. Initial audit was conducted to determine
delays in starting time. This lead to the proposal and imple-
mentation of “ﬁstula ﬁrst” initiative. Plan-do-study-act (PDSA)
cycle were completed and a re-audit was then carried out.
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sions did not start in time with a mean delay of 51.9 (
53.1) minutes. In addition, 47% of the lists overran the
ﬁnishing time with mean delay of 34.5 ( 47.9) minutes.
Implementation of “Fistula ﬁrst” signiﬁcantly improved the
number of late starting sessions to 56% with a mean delay
of 22.6 ( 26.7) minutes (p ¼ 0.001). It also reduced
overrunning lists to 35% with a mean delay in ﬁnishing time
of 28.2 ( 48.9) minutes (p>0.05). Looking at dialysis ac-
cess ﬁstula, intervention reduced late starting sessions from
87.5% to 60% with mean delay reduction from 52.7 ( 41.8)
to 20.13 ( 26.2) minutes (p ¼ 0.028).
Conclusion: Fistula ﬁrst proved its efﬁciency in reducing the
delay is session starting and this experience could be
adopted by other similar institutions.
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The care of venous leg ulcers (VLU) is associated with
prolonged disability, important socioeconomic impact, and
signiﬁcant psychosocial morbidity and can consume a sig-
niﬁcant amount of resources. In addition, approximately
50% of VLUs may recur within 10 years and they are marked
by a signiﬁcant component of chronicity.
Compression therapy remains the most popular and
effective method in management of venous ulcer. Although
surgical correction of superﬁcial venous incompetence was
found to reduce recurrence rate of ulceration, its role in
ulcer healing is not conﬁrmed. Our systematic review and
meta-analysis conﬁrmed that the quality of the evidence
available to support recommendations for operative man-
agement is mostly limited to level C evidence.
Moreover, different modalities of treating varicose veins
were intensively investigated in RCTs and they identiﬁed
similar efﬁciency and quality of life of endovenous ablation
and open surgery in treating varicose veins but less post-
operative pain, complication rates and recovery in the
endovenous group.
Hence, we are proposing a multi-center randomized
controlled trial to determine whether endovenous ablation
of incompetent superﬁcial veins in addition to best medical
treatment has any superior effect compared to best
medical treatment alone in regards to ulcer healing and
ulcer recurrence rates. The secondary objectives are; to
evaluate the cost effectiveness of the intervention for
incompetent superﬁcial veins in management of chronic
venous ulcers and to compare the commonly used endo-
venous ablation procedures in management of lower limb
varicose veins.Baroreceptor Activation Therapy for the Treatment of
Resistant Hypertension: First Case in the British Isles
A. El-Bakr, M.Y. Adeel, F. Sherif, M. Tubassam
Department of Vascular Surgery, University Hospital Galway, Ireland
Introduction: The need to treat resistant hypertension has
triggered the development of novel therapeutic options.
Several trials have shown that carotid baroreceptor activa-
tion is a safe, & effective approach in treating this condition.
Used in Europe for few years, this report describes the ﬁrst
case of surgical implantation of the Barostim neo device in
the British Isles.
Case Description: 53 years-old gentleman with medical
background of Sjogren’s syndrome, Type II diabetes, & drug-
resistant hypertension. The hypertension is thought to be
related to autonomic dysfunction, as no other causes for
secondary hypertension was found, despite exhaustive in-
vestigations. Through standard longitudinal neck incision,
exposure of the carotid bifurcation was done avoiding dis-
secting the carotid adventitia. Mapping of the carotid sinus
with the 2mm electrode was done. Upon testing, excellent
response with 20% blood pressure drop, & 10% heart rate
drop was elicited. The electrode was ﬁxed to the carotid
bulb using 6/0 prolene interrupted sutures. After creating
the infraclavicular submuscular pocket on the right chest
wall for the pulse generator, the electrode cable was
tunneled, & connected. Both wounds were closed in layers,
after repeat testing with satisfactory response. No imme-
diate postoperative complications were reported. The pa-
tient was discharged home on the following morning with a
plan for device activation after two weeks.
Discussion: Based on the initial test results, a successful
outcome is expected.
Clinical Conundrum: An Inﬂammatory AAA.A Cautionary
Tale
C. Baxter, A. El-Bakr, M. Tubassam
Western Vascular Institute, University College Hospital, Galway, NUIG, Ireland
Introduction: Inﬂammatory AAA account for 5e10% of all
AAA. Although the pathogenesis of inﬂammatory AAA ap-
pears to involve an immune response localized to the vessel
wall, the aetiology of the inﬂammatory reaction is un-
known. Chronic periaortitis is a spectrum of diseases
including inﬂammatory AAA. In most cases chronic peri-
aortitis is idiopathic; other causes are drugs, retroperitoneal
injury, infection and malignancy.
Case Description: A previously ﬁt and active 66yo man was
admitted undermedicswith blurring of vision and a suspected
TIA. During admission he c/o left ﬂank pain with CTshowing a
4.3cm inﬂammatory AAA, left hydronephrosis and right
ureteric stone. He required bilateral JJ stents and percuta-
neous nephrostomy due to persistent left hydronephrosis.
Autoimmune screen and temporal artery biopsy were nega-
tive. Subsequently he developed bilateral leg swelling and
duplex scan showed DVT. Then he developed RUQ pain and
obstructive jaundice. Investigations showed gall stones,
